Insulin sensitivity and glucose control
Regulation of glucose disposal, insulin response, and metabolic flexibility.
D01 · EOL evidence domain
Energy balance, glucose regulation, nutrition, and metabolic resilience.
Canonical subdomains
Regulation of glucose disposal, insulin response, and metabolic flexibility.
Lab and wearable markers used to quantify glucose and insulin dynamics.
Lean mass, fat mass, waist circumference, visceral adiposity, and body recomposition.
TG/HDL ratio, remnant cholesterol, and insulin-resistant lipid patterns.
Liver fat accumulation, transaminases, insulin resistance, and metabolic liver risk.
Satiety hormones, appetite regulation, weight-loss pharmacology, and rebound risk.
Meal timing, fasting windows, metabolic switching, and safety limits.
Protein adequacy, amino-acid signaling, muscle preservation, and satiety.
Uric acid as marker of metabolic syndrome, gout risk, fructose, alcohol, and renal handling.
Protein glycation, advanced glycation end-products, cooking methods, and glucose exposure.
Meal composition, timing, order of eating, and CGM-based behavioral feedback.
Inflammatory signaling from adipose tissue and metabolic dysfunction.
Ability to switch between fuel sources and maintain energy metabolism.
Commercial claims around cleansing, parasite cleanses, detox teas, and metabolic resets.
Gut microbes, short-chain fatty acids, bile acids, appetite, and glucose regulation.
Diet response by phenotype, genotype, microbiome, and wearable data.